Venous but not skeletal muscle interstitial nitric oxide is increased during hypobaric hypoxia

Urs Leuenberger, Douglas Johnson, Joseph Loomis, Kristen S. Gray, David A. MacLean

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Systemic hypoxia leads to peripheral vasodilation that serves to counteract the decrease in peripheral oxygen (O2) delivery. Skeletal muscle vasodilation associated with hypoxia is due to release of vasodilator substances such as adenosine and/or nitric oxide (NO). We hypothesized that skeletal muscle may act as a source of NO during exposure to hypoxia. Therefore, we measured NO in forearm venous plasma and in skeletal muscle interstitial dialysate in seven healthy young men during exposure to simulated altitude of 2,438 and 4,877 m (20 min at each level) in a hypobaric chamber. O2 saturation (mean ± SEM) fell from 98.0 ± 0.2% at ambient conditions to 91.0 ± 0.4% at 2,438 m and to 73.2 ± 4.4% at 4,877 m (P<0.05). While blood pressure remained unchanged, heart rate increased in a graded fashion (P<0.05). Plasma NO (chemiluminescence method) rose from 11.6 ± 1.3 to 16.9 ± 2.9 μM at 2,438 m (P<0.05) but remained similar at 16.4 ± 2.3 μM at 4,877 m (NS). In contrast, skeletal muscle microdialysate NO levels were lower than plasma NO (P<0.01) and did not change during simulated altitude. Thus, hypoxia produced by simulated high altitude exposure leads to an increase in plasma but not skeletal muscle interstitial NO. These data support an important role of NO in the peripheral vascular responses to hypoxia. The differential responses of plasma vs. interstitial NO during hypoxia suggest an endothelial or intravascular source of NO.

Original languageEnglish (US)
Pages (from-to)457-461
Number of pages5
JournalEuropean Journal of Applied Physiology
Volume102
Issue number4
DOIs
StatePublished - Mar 1 2008

Fingerprint

Nitric Oxide
Skeletal Muscle
Vasodilation
Hypoxia
Dialysis Solutions
Luminescence
Vasodilator Agents
Forearm
Adenosine
Blood Vessels
Heart Rate
Oxygen
Blood Pressure

All Science Journal Classification (ASJC) codes

  • Orthopedics and Sports Medicine
  • Public Health, Environmental and Occupational Health
  • Physiology (medical)

Cite this

Leuenberger, Urs ; Johnson, Douglas ; Loomis, Joseph ; Gray, Kristen S. ; MacLean, David A. / Venous but not skeletal muscle interstitial nitric oxide is increased during hypobaric hypoxia. In: European Journal of Applied Physiology. 2008 ; Vol. 102, No. 4. pp. 457-461.
@article{f15a3de6a35743dc9c48bcc5e13950e0,
title = "Venous but not skeletal muscle interstitial nitric oxide is increased during hypobaric hypoxia",
abstract = "Systemic hypoxia leads to peripheral vasodilation that serves to counteract the decrease in peripheral oxygen (O2) delivery. Skeletal muscle vasodilation associated with hypoxia is due to release of vasodilator substances such as adenosine and/or nitric oxide (NO). We hypothesized that skeletal muscle may act as a source of NO during exposure to hypoxia. Therefore, we measured NO in forearm venous plasma and in skeletal muscle interstitial dialysate in seven healthy young men during exposure to simulated altitude of 2,438 and 4,877 m (20 min at each level) in a hypobaric chamber. O2 saturation (mean ± SEM) fell from 98.0 ± 0.2{\%} at ambient conditions to 91.0 ± 0.4{\%} at 2,438 m and to 73.2 ± 4.4{\%} at 4,877 m (P<0.05). While blood pressure remained unchanged, heart rate increased in a graded fashion (P<0.05). Plasma NO (chemiluminescence method) rose from 11.6 ± 1.3 to 16.9 ± 2.9 μM at 2,438 m (P<0.05) but remained similar at 16.4 ± 2.3 μM at 4,877 m (NS). In contrast, skeletal muscle microdialysate NO levels were lower than plasma NO (P<0.01) and did not change during simulated altitude. Thus, hypoxia produced by simulated high altitude exposure leads to an increase in plasma but not skeletal muscle interstitial NO. These data support an important role of NO in the peripheral vascular responses to hypoxia. The differential responses of plasma vs. interstitial NO during hypoxia suggest an endothelial or intravascular source of NO.",
author = "Urs Leuenberger and Douglas Johnson and Joseph Loomis and Gray, {Kristen S.} and MacLean, {David A.}",
year = "2008",
month = "3",
day = "1",
doi = "10.1007/s00421-007-0601-x",
language = "English (US)",
volume = "102",
pages = "457--461",
journal = "European Journal of Applied Physiology",
issn = "1439-6319",
publisher = "Springer Verlag",
number = "4",

}

Venous but not skeletal muscle interstitial nitric oxide is increased during hypobaric hypoxia. / Leuenberger, Urs; Johnson, Douglas; Loomis, Joseph; Gray, Kristen S.; MacLean, David A.

In: European Journal of Applied Physiology, Vol. 102, No. 4, 01.03.2008, p. 457-461.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Venous but not skeletal muscle interstitial nitric oxide is increased during hypobaric hypoxia

AU - Leuenberger, Urs

AU - Johnson, Douglas

AU - Loomis, Joseph

AU - Gray, Kristen S.

AU - MacLean, David A.

PY - 2008/3/1

Y1 - 2008/3/1

N2 - Systemic hypoxia leads to peripheral vasodilation that serves to counteract the decrease in peripheral oxygen (O2) delivery. Skeletal muscle vasodilation associated with hypoxia is due to release of vasodilator substances such as adenosine and/or nitric oxide (NO). We hypothesized that skeletal muscle may act as a source of NO during exposure to hypoxia. Therefore, we measured NO in forearm venous plasma and in skeletal muscle interstitial dialysate in seven healthy young men during exposure to simulated altitude of 2,438 and 4,877 m (20 min at each level) in a hypobaric chamber. O2 saturation (mean ± SEM) fell from 98.0 ± 0.2% at ambient conditions to 91.0 ± 0.4% at 2,438 m and to 73.2 ± 4.4% at 4,877 m (P<0.05). While blood pressure remained unchanged, heart rate increased in a graded fashion (P<0.05). Plasma NO (chemiluminescence method) rose from 11.6 ± 1.3 to 16.9 ± 2.9 μM at 2,438 m (P<0.05) but remained similar at 16.4 ± 2.3 μM at 4,877 m (NS). In contrast, skeletal muscle microdialysate NO levels were lower than plasma NO (P<0.01) and did not change during simulated altitude. Thus, hypoxia produced by simulated high altitude exposure leads to an increase in plasma but not skeletal muscle interstitial NO. These data support an important role of NO in the peripheral vascular responses to hypoxia. The differential responses of plasma vs. interstitial NO during hypoxia suggest an endothelial or intravascular source of NO.

AB - Systemic hypoxia leads to peripheral vasodilation that serves to counteract the decrease in peripheral oxygen (O2) delivery. Skeletal muscle vasodilation associated with hypoxia is due to release of vasodilator substances such as adenosine and/or nitric oxide (NO). We hypothesized that skeletal muscle may act as a source of NO during exposure to hypoxia. Therefore, we measured NO in forearm venous plasma and in skeletal muscle interstitial dialysate in seven healthy young men during exposure to simulated altitude of 2,438 and 4,877 m (20 min at each level) in a hypobaric chamber. O2 saturation (mean ± SEM) fell from 98.0 ± 0.2% at ambient conditions to 91.0 ± 0.4% at 2,438 m and to 73.2 ± 4.4% at 4,877 m (P<0.05). While blood pressure remained unchanged, heart rate increased in a graded fashion (P<0.05). Plasma NO (chemiluminescence method) rose from 11.6 ± 1.3 to 16.9 ± 2.9 μM at 2,438 m (P<0.05) but remained similar at 16.4 ± 2.3 μM at 4,877 m (NS). In contrast, skeletal muscle microdialysate NO levels were lower than plasma NO (P<0.01) and did not change during simulated altitude. Thus, hypoxia produced by simulated high altitude exposure leads to an increase in plasma but not skeletal muscle interstitial NO. These data support an important role of NO in the peripheral vascular responses to hypoxia. The differential responses of plasma vs. interstitial NO during hypoxia suggest an endothelial or intravascular source of NO.

UR - http://www.scopus.com/inward/record.url?scp=45549098975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45549098975&partnerID=8YFLogxK

U2 - 10.1007/s00421-007-0601-x

DO - 10.1007/s00421-007-0601-x

M3 - Article

C2 - 17985154

AN - SCOPUS:45549098975

VL - 102

SP - 457

EP - 461

JO - European Journal of Applied Physiology

JF - European Journal of Applied Physiology

SN - 1439-6319

IS - 4

ER -